SYNLAB AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.42 EUR | -0.38% |
|
+1.36% | -8.68% |
| 04-22 | Synlab Faces Cyber Attack in Italy | MT |
| 04-21 | Dpa-AFX Overview: COMPANIES - The most important news from the weekend | DP |
Business Summary
Number of employees: 23,538
Sales per Business
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Human Medicine
97.6
%
| 3,168 | 97.5 % | 2,572 | 97.6 % | -18.79% |
Veterinary Medicine
1.1
%
| 42 | 1.3 % | 29 | 1.1 % | -29.98% |
Trading Goods and Services
0.7
%
| 20 | 0.6 % | 20 | 0.7 % | -1.03% |
Environmental and Other Analysis, Studies, Expertise
0.3
%
| 10 | 0.3 % | 9 | 0.3 % | -10.26% |
Software Solutions and Services
0.2
%
| 12 | 0.4 % | 6 | 0.2 % | -53.57% |
Sales per region
| EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Germany
20.3
%
| 703 | 21.6 % | 536 | 20.3 % | -23.75% |
France
19.9
%
| 674 | 20.7 % | 524 | 19.9 % | -22.24% |
South
17.5
%
| 0 | 0.0 % | 461 | 17.5 % | - |
Italy
13.0
%
| 355 | 10.9 % | 343 | 13.0 % | -3.59% |
United Kingdom
13.0
%
| - | - | 343 | 13.0 % | - |
North & East
8.3
%
| 913 | 28.1 % | 217 | 8.3 % | -76.17% |
Latin America
8.0
%
| 192 | 5.9 % | 211 | 8.0 % | +9.76% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 56 | 21-01-25 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 21-01-25 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Chief Operating Officer | 40 | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
Mark Reinhard
IRC | Investor Relations Contact | - | 20-12-31 |
Walla Fabian
SEC | Corporate Secretary | - | - |
| Human Resources Officer | - | - | |
| Corporate Officer/Principal | - | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 21-01-10 |
| Founder | 63 | 97-12-31 | |
Peter Catterall
BRD | Director/Board Member | 55 | 21-01-10 |
Marc Welters
BRD | Director/Board Member | - | 21-04-28 |
Barbara Lambert
BRD | Director/Board Member | 62 | 21-01-10 |
Karin Bierstedt
BRD | Director/Board Member | 52 | 21-04-28 |
Ute Hasholzner
BRD | Director/Board Member | 65 | 21-04-28 |
| Director/Board Member | 62 | 21-04-28 | |
Iris Schopper
BRD | Director/Board Member | 36 | 21-04-28 |
| Director/Board Member | - | 21-04-28 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 222,222,222 | 31,594,456 ( 14.22 %) | 2,447,000 ( 1.101 %) | 14.22 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
SYNLAB AG 1.13% | 2,518,864 | 1.13% | 29,788,086 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
SYNLAB Bondco Plc
 SYNLAB Bondco Plc Financial ConglomeratesFinance SYNLAB Bondco Plc offers medical diagnostics for patients, practicing doctors, clinics and the pharmaceutical industry. The company was founded on March 23, 2015 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.5
EUR
Average target price
14.5
EUR
Spread / Average Target
+38.10%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.33% | 8.25B | |
| +39.20% | 3.58B | |
| -39.11% | 2.46B | |
| -7.35% | 2.38B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B | |
| -14.42% | 1.03B | |
| -16.56% | 878M |
- Stock Market
- Equities
- SYAB Stock
- SYAB Stock
- Company SYNLAB AG
